Fast Five Quiz: Multiple Myeloma Management

Joshua Richter, MD; Emmanuel C. Besa, MD

May 16, 2023

Erythropoietin-stimulating agents are used either alone or in conjunction with chemotherapy in MM to augment erythropoiesis and treat anemia, which can lead to a significant improvement in a patient's performance status and quality of life.

Chemotherapy is used to reduce the burden of disease. Bisphosphonates promote bone healing and provide secondary prophylaxis against skeletal-related events. Immunosuppressants modify the body's immune response by inhibiting key factors in the immune system.

Learn more about treatments used in MM.

Editor's Recommendations

Multiple Myeloma

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Joshua Richter, Emmanuel C. Besa. Fast Five Quiz: Multiple Myeloma Management - Medscape - May 16, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Fast Five Quiz: Multiple Myeloma Management

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Joshua Richter, MD

Emmanuel C. Besa, MD

Comments

Email This

Feedback